Douglas L. Boggs PharmD
Associate Research Scientist in Psychiatry
Departments & Organizations
Education
- Pharm.D., University of Florida, 2003
- M.S., University of Texas School of Pharmacy, 2005
- B.S., University of Florida, 2009
Selected Publications
- Boggs DL, Kelly DL. Antipsychotic Therapeutics. In The Year in Schizophrenia Volume 2. Editors: Thaker G, Carpenter WT. Clinical Publishing. December 2008 p 159 – 178
- Fischer BA, Boggs DL. The Role of Antihistaminic Effects in the Misuse of Quetiapine: A Case Report and Review of the Literature. (on-line: November 6, 2009) Neurosci Biobehav Rev. 2010; 34(4): 555-8. Pubmed PMID: 19896973
- Boggs DL, Kelly DL, Nelson MW, Yu Y, Feldman S, McMahon RP, Conley RR. Quetiapine at High Doses for the Treatment of Refractory Schizophrenia. (letter) (on-line: February 20, 2008) Schizophr Res 2008; 101(1-3): 347-8. Pubmed PMID: 18281197
